SLP Stock UPDATES Simulations Plus (SLP) 5.98 08/02/2014 17:

New Post Public Reply Private Reply Replies (0) Message Board

Aug 2, 2014 at 6:02 PM

Simulations Plus (SLP) 5.98 $SLP

Simulations Plus declares USD0.05 quarterly dividend
M2 - Mon Jul 28, 8:44AM CDT
Simulations Plus, Inc. (NASDAQ: SLP) said that its board of directors has declared its next ongoing quarterly cash dividend of USD0.05 per share to its shareholders.

Simulations Plus Announces Quarterly Cash Dividend
Business Wire - Fri Jul 25, 7:01AM CDT
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that its board of directors has declared its next ongoing quarterly cash dividend of $0.05 per share to its shareholders. This cash dividend will be distributed on Monday August 11, 2014, for shareholders of record as of Monday, August 4, 2014.

Simulations Plus Provides Additional Details Regarding Cognigen Acquisition
Business Wire - Thu Jul 24, 5:04PM CDT
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today provided additional details regarding its Agreement and Plan of Merger (the "Agreement"

with Cognigen Corporation ("Cognigen"

of Buffalo, New York, announced yesterday.

Simulations Plus to Acquire Cognigen Corporation
Business Wire - Wed Jul 23, 9:45PM CDT
Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that it has entered into an Agreement and Plan of Merger (the "Agreement"

with Cognigen Corporation of Buffalo, New York.

Simulations Plus revenues up 20.9%
M2 - Mon Jul 07, 8:59AM CDT
Simulations Plus, Inc. (NASDAQ: SLP) said net sales for the third quarter of 2014 increased 20.9 percent compared to the same quarter in 2013, fromUSD3.095m to USD3.741m.

US EPA buys multiple licenses of Simulations Plus Software
M2 - Thu Jul 03, 8:50AM CDT
Simulations Plus, Inc. (NASDAQ: SLP) said that the US Environmental Protection Agency has purchased five licenses of both its best-in-class GastroPlus and ADMET Predictor software programs.

Simulations Plus Sets Date for 3rd Quarter 2014 Earnings Release and Conference Call
Business Wire - Thu Jul 03, 7:15AM CDT
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of software and consulting services for pharmaceutical R&D and environmental toxicology, announced that it expects to file its quarterly report on Form 10-Q for the third quarter of its 2014 fiscal year, ended May 31, 2014, with the U.S. Securities and Exchange Commission on Tuesday, July 8, 2014. Chairman and Chief Executive Officer Walt Woltosz will host a conference call to discuss the Company's performance on Tuesday, July 8, at 1:15 p.m. PT/4:15 p.m. ET.

Simulations Plus Reports Third Quarter FY2014 Financial Results
Business Wire - Thu Jul 03, 7:00AM CDT
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today reported financial results for its third quarter of fiscal year 2014 ended May 31, 2014 (3QFY14) and first nine months of fiscal year 2014 (9moFY14) compared to the third quarter (3QFY13) and first nine months of fiscal year 2013 (9moFY13).

U.S. Environmental Protection Agency Purchases Multiple Licenses of Simulations Plus Software
Business Wire - Wed Jul 02, 7:00AM CDT
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, announced that the U.S. Environmental Protection Agency (EPA) has purchased five licenses of both its best-in-class GastroPlus(TM) and ADMET Predictor(TM) software programs.

Nasdaq stocks posting largest percentage decreases
AP - Tue Jul 01, 12:22PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:

TSRL, Inc. Announces Agreement With Software Licensee
Marketwire - Wed Jun 18, 1:31AM CDT
Therapeutic Systems Research Laboratories, (TSRL), Inc. announced today that it has entered into a Termination and Non-Assertion Agreement (the "Agreement"

with Simulations Plus, Inc., a California corporation ("SLP"

. Under the terms of the Agreement, SLP and TSRL agreed to terminate the Exclusive Software Licensing Agreement, under which TSRL licensed to SLP Software Technology and Databases in return for royalty payments. SLP will pay TSRL a total consideration of $6 million.

Simulations Plus Reports Preliminary Revenues for Third Fiscal Quarter FY2014
Business Wire - Tue Jun 03, 7:00AM CDT
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for its third fiscal quarter of fiscal year 2014, ended May 31, 2014 (3QFY14).

Simulations Plus Releases MedChem Studio Version 4.0 and MedChem Designer 3.0
Business Wire - Thu May 22, 7:01AM CDT
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that it has released version 4.0 of its powerful MedChem Studio(TM) and version 3.0 of its companion MedChem Designer(TM) software.

Simulations Plus Predictor improves all predictions, adds new ones
M2 - Thu Mar 27, 7:43AM CDT
Simulations Plus, Inc. (NASDAQ: SLP) said it has released version 7.0 of its best-in-class ADMET Predictor molecular property prediction software.

Simulations Plus Shares Up 46.7% Since SmarTrend's Buy Recommendation (SLP)
Comtex SmarTrend(R) - Wed Mar 26, 11:01AM CDT
SmarTrend identified an Uptrend for Simulations Plus (NASDAQ:SLP) on June 4th, 2013 at $4.57. In approximately 10 months, Simulations Plus has returned 46.70% as of today's recent price of $6.70.

Simulations Plus Releases ADMET Predictor Version 7.0
Business Wire - Wed Mar 26, 7:02AM CDT
Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that it has released version 7.0 of its best-in-class ADMET Predictor(TM) molecular property prediction software.

Simulations Plus Has Returned 36.3% Since SmarTrend Recommendation (SLP)
Comtex SmarTrend(R) - Wed Mar 19, 9:47AM CDT
SmarTrend identified an Uptrend for Simulations Plus (NASDAQ:SLP) on June 4th, 2013 at $4.57. In approximately 10 months, Simulations Plus has returned 36.30% as of today's recent price of $6.22.

Simulations Plus Signs New Partnership Agreement in China
Business Wire - Tue Mar 18, 7:01AM CDT
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that it has signed a distributor agreement with the Research Institute for Liver Diseases (RILD) in Shanghai, People's Republic of China.

Simulations Plus Announces Success in COX-2/COX-1 Drug Design Project
Business Wire - Fri Mar 14, 7:00AM CDT
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that its second NCE (new chemical entity) initiative, which involved using Simulations Plus software to design molecules to inhibit COX-2, has been a success as determined by synthesis and testing by a third-party lab. Three of the four molecules it has designed are potent inhibitors of both cyclooxygenase-2 (COX-2) and COX-1 enzymes. The fourth inhibits COX-2 but only weakly inhibits COX-1.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

California Accelerates AI Law with Newsom's Bold Move

Pushing AI Regulations into High Gear I'll tell you what—it's about time somebody shook things up in the AI world with more than empty promises. Governor Newsom's executive order is doing just that, fast-tracking the timeline for implementing California's SB 813. This move is like giving speed boots to the legislative process, revving up the rules to ensure AI doesn't...

AI Ambassadors Rethink Arbitration's Future

Navigating the AI Terrain in Arbitration It's 2026 and artificial intelligence isn't just a buzzword anymore; it's reshaping every corner of how disputes get resolved. The American Arbitration Association (AAA) has jumped into the mix, launching an AI Ambassador program to tackle a wave of AI-induced challenges. These aren't just academic exercises—this is a hard-nosed...

Heafner Takes Helm at HGTC Amid Strategic Shifts

A New Era for HGTC with Dr. Heafner at the Wheel Out of the frying pan and into the fire—Dr. Lori Heafner is stepping up to lead Horry-Georgetown Technical College (HGTC) with a clean slate and a hefty load of responsibility come January 2027. After enduring an intense national search by the Area Commission, she beat out tough competition to earn the role. It's not just...

IRS Views Challenge Tax-Engineered Healthcare Schemes

Nonprofit Models Shine Amid IRS Scrutiny Out in Oxnard, California, there's a brewing storm in the healthcare sector. No, it's not a billing error or yet another scandal. We're talking about a seismic shift that could poke holes in those tax-engineered Section 105(b) programs, all thanks to some hard-hitting IRS memoranda. The Nonprofit–TPA Model: A Safer Bet? Enter...

Invictus Pharmacy Secures LegitScript Certification Status

A New Chapter for Invictus Pharmacy In a world tangled up in red tape, Invictus Pharmacy somehow managed to cut a clear path by earning the LegitScript Healthcare Merchant Certification. Now, it seems like they've joined the ranks of the big players, including the likes of Amazon Pharmacy. It’s not just a shiny badge on their website, folks. It’s better access to...

Buffett Steps Down, New Faces at Berkshire Hathaway

End of an Era: Warren Buffett's Retirement Warren Buffett—there's a name that's echoed through the halls of investment for decades. Today, he's pulling down the curtain as Chairman of Berkshire Hathaway (NYSE: BRK). No fanfare, just a nod to the inevitable with his classic, humor-tinged confession: 'Father Time always wins.' Can’t argue with the man who’s seen the...

Ensuring Your Radon Mitigation System Stays Effective

Radon Mitigation: A Critical Measure for Home Safety Homeowners, you're probably aware of the ticking health time bomb known as radon. Not just an annoying gas, this colorless, odorless beast lurks quietly, threatening family health if not managed right. Mitch Kelley, a specialist in radon testing with Basement Solutions in Mankato, Minnesota, lays out a no-fuss guide to...

Debbie's Dream Foundation Launches 2026 Youth Art Contest

Young Artists Called to Inspire a Cancer-Free World What's the first image that pops into your head when you think of a world free from cancer? That's the magic question on deck for this year's Youth Art Contest by Debbie's Dream Foundation. Imaginations are set to run wild as the competition opens its gates to artists under 18, calling for visions splashed across...

Debt Crisis Looms: Social Security at Risk

Debt Reality: A National Concern with Global Implications When it comes to the U.S. federal debt situation, the latest report from the National Seniors Policy Center is lighting a fire like no other, warning us that we're not crying wolf here. We've got fiscal numbers that may not sit well at breakfast. With roughly 67 cents of every new buck Uncle Sam borrows going to...

Sierra Ridge Advisors Join Gateway Financial Milestone

Big Moves in the Financial Advisory World Let's dive right in. Here's a real shakeup in the advisory realm: 28 financial advisors and team members from Sierra Ridge Advisor Group are packing their bags for Gateway Financial Partners. We're talking about a significant shift involving $825 million in assets under advisement. Instead of sticking with Sierra Ridge as it...